[144] AMBARELLA INC SEC Filing
Rhea-AI Filing Summary
Form 144 filed for Ambarella, Inc. (AMBA): The notice reports a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney on 09/19/2025 with an aggregate market value of $84,000. The shares were acquired as performance shares on 03/15/2021. The filer, identified in related sales as Christopher Day, sold common shares on 07/14/2025 (2,907 shares), 09/08/2025 (1,772 shares), 09/17/2025 (361 shares), and 09/18/2025 (829 shares). The filing includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Disclosure completeness: Form 144 includes acquisition date, nature of acquisition, broker, proposed sale date, and recent sales history.
- Acquisition transparency: Indicates securities were granted as performance shares on 03/15/2021.
Negative
- Insider selling: The filer (Christopher Day) reported multiple sales totaling 7,869 shares across 07/14/2025 to 09/18/2025, which may reduce insider ownership.
- No operational or financial context: The filing contains no company performance or reason for sales beyond standard representations.
Insights
Insider selling activity is documented but appears routine; no new company disclosures are included.
The filing documents continued disposals by an insider, Christopher Day, across multiple dates and a proposed sale of 1,000 shares on 09/19/2025 via Morgan Stanley. Sales over the past two months total meaningful share counts (7,869 shares reported). There is no accompanying financial or operational disclosure in this notice; its informational impact is limited to insider liquidity and ownership changes.
Form 144 meets procedural requirements and includes requisite insider representation.
The form states acquisition source (performance shares dated 03/15/2021) and confirms the filer’s certification about undisclosed material information. The notice identifies broker details and the issuer’s outstanding shares count (42,689,006). From a compliance perspective, the filing appears complete for a Rule 144 sale notice; it does not allege any regulatory exceptions or waivers.